Epigenetic alterations underlie a wide variety of pathologies, including cancer, by regulating gene activity. There is a great deal of potential for the use of epigenetics as biomarkers for better understanding the early stage biological response and molecular mechanisms. The research in my lab focuses on identifying environmental epigenetic biomarkers and understanding their relationship to risk of disease.
